The Multiple Facets of Multiple Sclerosis

Course overview

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, progressive central nervous system (CNS) disease that leads to irreversible disability. MS affects people of all ages, is commonly diagnosed in early adulthood, and is the leading cause of non-traumatic neurological disability in young adults. An abnormal immune response causes inflammation in MS. As knowledge of the disease has evolved, treatment options and approaches have shifted and improved. Disease modifying therapies (DMTs) modify disease course by reducing relapse rate and disability progression. Differing mechanisms of action, administration avenues, dosing, and DMT safety concerns offer healthcare providers and patients many treatment options. A knowledgeable, informed pharmacy team is prepared to educate and counsel patients about MS management.